Abstract
Aim and Objective: Diabetes mellitus is associated with inflammation and increased oxidative stress. In the current study, we aimed to investigate the relationship between type 2 diabetes mellitus (T2DM) and serum pro-oxidant-antioxidant balance (PAB) in a large populationbased study.
Methods: In this cross-sectional study, 7888 individuals were recruited as part of the Mashhad Stroke and Heart Atherosclerotic Disorders (MASHAD) cohort study. Participants were divided into three groups based on their serum PAB values (levels < 36.4, 36.4-82.6 and > 82.6 HK). Serum PAB values were measured using a colorimetric method and enzyme-linked immune sorbent assay (ELISA). Results: Serum PAB in subjects with and without diabetes was reported 76.85 ± 61.07 HK and 69.51 ± 55.50 HK. In subjects with a serum PAB > 82.6 HK the risk of T2DM was 1.2 fold higher in comparison to subjects with a serum PAB < 36.4 HK (OR: 1.26, 95% CI: 1.09 – 1.47, P-value: 0.002). This association remained significant after adjustment for confounding factors in multivariable analysis (OR: 1.19, 95% CI: 1.02 – 1.38, P-value: 0.027). Conclusion: Increased pro-oxidant levels may be a major complication of T2DM in our study subjects and PAB could be an indicator of higher oxidative stress in T2DM patients from northeastern Iran.Keywords: Pro-oxidant-Antioxidant balance, Type 2 diabetes mellitus, MASHAD cohort study, oxidative stress, inflammation.
Combinatorial Chemistry & High Throughput Screening
Title:Serum Pro-oxidant-antioxidant Balance in Subjects with Type 2 Diabetes Mellitus
Volume: 24 Issue: 9
Author(s): Mahsa Ahmadnezhad*, Hamideh Ghazizadeh*, Moniba Bijari*, Mohammad Reza Oladi*, Habibollah Esmaily, Seyed Javad Hoseini, Elham Barati, Samaneh Silakhori, Maryam Mohammadi-Bajgiran, Hafezeh Davari, Mohammad Reza Parizadeh, Naghme Mokhber, Payam Sharifan, Seyed Rafie Aref-Hosseini, Gordon A Ferns, Mohsen Moohebati and Majid Ghayour-Mobarhan
Affiliation:
- Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad,Iran
- Student Research Committee, Mashhad University of Medical Sciences, Mashhad,Iran
- Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad,Iran
- International UNESCO Center for Health- Related Basic Sciences and Human Nutrition, Mashhad University of Medical Sciences, Mashhad,Iran
Keywords: Pro-oxidant-Antioxidant balance, Type 2 diabetes mellitus, MASHAD cohort study, oxidative stress, inflammation.
Abstract: Aim and Objective: Diabetes mellitus is associated with inflammation and increased oxidative stress. In the current study, we aimed to investigate the relationship between type 2 diabetes mellitus (T2DM) and serum pro-oxidant-antioxidant balance (PAB) in a large populationbased study.
Methods: In this cross-sectional study, 7888 individuals were recruited as part of the Mashhad Stroke and Heart Atherosclerotic Disorders (MASHAD) cohort study. Participants were divided into three groups based on their serum PAB values (levels < 36.4, 36.4-82.6 and > 82.6 HK). Serum PAB values were measured using a colorimetric method and enzyme-linked immune sorbent assay (ELISA). Results: Serum PAB in subjects with and without diabetes was reported 76.85 ± 61.07 HK and 69.51 ± 55.50 HK. In subjects with a serum PAB > 82.6 HK the risk of T2DM was 1.2 fold higher in comparison to subjects with a serum PAB < 36.4 HK (OR: 1.26, 95% CI: 1.09 – 1.47, P-value: 0.002). This association remained significant after adjustment for confounding factors in multivariable analysis (OR: 1.19, 95% CI: 1.02 – 1.38, P-value: 0.027). Conclusion: Increased pro-oxidant levels may be a major complication of T2DM in our study subjects and PAB could be an indicator of higher oxidative stress in T2DM patients from northeastern Iran.Export Options
About this article
Cite this article as:
Ahmadnezhad Mahsa *, Ghazizadeh Hamideh *, Bijari Moniba *, Oladi Reza Mohammad *, Esmaily Habibollah , Hoseini Javad Seyed , Barati Elham , Silakhori Samaneh , Mohammadi-Bajgiran Maryam , Davari Hafezeh , Parizadeh Reza Mohammad , Mokhber Naghme , Sharifan Payam , Aref-Hosseini Rafie Seyed , Ferns A Gordon , Moohebati Mohsen and Ghayour-Mobarhan Majid , Serum Pro-oxidant-antioxidant Balance in Subjects with Type 2 Diabetes Mellitus, Combinatorial Chemistry & High Throughput Screening 2021; 24 (9) . https://dx.doi.org/10.2174/1386207323999201103203153
DOI https://dx.doi.org/10.2174/1386207323999201103203153 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
New Antipsychotics and Schizophrenia: A Review on Efficacy and Side Effects
Current Medicinal Chemistry Structural Basis of Infectious and Non-Infectious Amyloids
Current Alzheimer Research Diabetic CVD – Focus on Vitamin D
Cardiovascular & Hematological Agents in Medicinal Chemistry Glycogen Synthase Kinase-3 - An Overview of An Over-Achieving Protein Kinase
Current Drug Targets Common Therapeutic Strategies for Diabetic Retinopathy and Glaucoma
Current Drug Therapy <i>In Silico</i> ADMET Evaluation of Natural DPP-IV Inhibitors for Rational Drug Design against Diabetes
Current Drug Metabolism Sulfur- and Acyl Chain-Dependent Influence of 2-Methoxy-Lysophosphatidylcholine Analogues on β Pancreatic Cells
Current Topics in Medicinal Chemistry Pigment Epithelium-derived Factor (PEDF) and Cardiometabolic Disorders
Current Pharmaceutical Design Role of Brain NUCB2/nesfatin-1 in the Stress-induced Modulation of Gastrointestinal Functions
Current Neuropharmacology Approach to the Patient with Subclinical Cushing’s Syndrome
Current Pharmaceutical Design Hydrogels Based on Interpenetrating Network of Chitosan and Polyvinyl Pyrrolidone for pH-Sensitive Delivery of Repaglinide
Current Drug Discovery Technologies ALA, Fatty Fish or Marine n-3 Fatty Acids for Preventing DM?: A Systematic Review and Meta-Analysis
Current Diabetes Reviews Lipid-Lowering Drugs Acting at the Level of the Gastrointestinal Tract
Current Pharmaceutical Design Current Status of CETP Inhibitors in the Treatment of Hyperlipidemia: An Update
Current Clinical Pharmacology Improved Lipid Target Level Attainment in Patients with Peripheral Artery Disease
Current Vascular Pharmacology Urotensin II: A Vascular Mediator in Health and Disease
Current Vascular Pharmacology Mechanisms of Dexamethasone-Induced Hypertension
Current Hypertension Reviews Possible Usefulness of Growth Hormone/Insulin-like Growth Factor-I Axis in Alzheimer’s Disease Treatment
Endocrine, Metabolic & Immune Disorders - Drug Targets Current Nanotechnological Approaches for an Effective Delivery of Bioactive Drug Molecules to Overcome Drug Resistance Tuberculosis
Current Pharmaceutical Design “Something is Wrong in the Ras Kingdom” - Evidence for the Involvement of p21Ras/MAP Kinase in Autoimmune Diseases
Current Rheumatology Reviews